Radial Announces $50 Million In Venture Funding

Mental health provider organization Radial announced it has raised $50 million in venture funding to create access to advanced mental health treatments such as neuromodulation and rapid-acting medications. The company is backed by General Catalyst, who led the Series A funding round, and additional investors Solari Capital, JSL Health Capital, Founder Collective, BoxGroup, Scrub Capital, and Diede van Lamoen.

Radial is developing clinical infrastructure, reimbursement tools, and artificial intelligence-guided decision support designed around novel psychiatry treatments, including transcranial magnetic stimulation, Spravato, a fast-acting antidepressant, and other interventional therapies. Their goal is to make transformative brain medicine accessible . . .